Gastrointestinal Cancer
Latest News
No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s
There is no evidence that GLP-1 RA use increases pancreatic cancer risk compared with basal insulin up to 7 years.
Feature
Radiation Oncologists Fight for Payment Reform Amid Cuts
Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for...
From the Journals
Standard Therapy Beats Out Primary Surgery in Rectal Cancer
A new study tests whether patients with locally advanced rectal cancer with MRI-predicted negative mesorectal fascia can skip preoperative...
From the Journals
SUDs rates highest in head, neck, and gastric cancer survivors
Alcohol use disorder was the most common type of SUD across multiple subtypes of cancer patients.
News from the FDA/CDC
FDA Rejects GI Cancer Drug Over Manufacturing Issues
Zolbetuximab was under priority review as the first agent specifically for locally advanced unresectable or metastatic HER2-negative gastric or...
From the Journals
Gastric Cancer Survival Differs by Race and Ethnicity
Researchers analyzed gastric cancer survival outcomes by race and ethnicity, treatment type, and a range of other factors.
From the Journals
GLP-1 RAs Associated With Reduced Colorectal Cancer Risk in Patients With Type 2 Diabetes
More profound effects were seen in patients with overweight or obesity, “suggesting a potential protective effect against CRC partially mediated...
Conference Coverage
Fewer than 1 out of 4 patients with HCV-related liver cancer receive antivirals
This study and others suggest that these practice-altering agents are underutilized. Greater awareness of direct-acting antiviral agents is needed...
Conference Coverage
More than one-third of adults in the US could have NAFLD by 2050
Findings suggest that health care systems should prepare for “large increases” in cases of hepatocellular carcinoma (HCC) and need for liver...
Latest News
ASCO details how to manage ongoing cancer drug shortage
“This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”
News
Pancreatic cystic neoplasms rarely turn cancerous, study shows
Study is the first to report the proportion of pancreatic cancers that develop from cystic neoplasms.